[EN] INDAZOLYL THIADIAZOLAMINES AND RELATED COMPOUNDS FOR INHIBITION OF RHO-ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE [FR] THIADIAZOLAMINES INDAZOLYLE ET COMPOSÉS APPARENTÉS POUR L'INHIBITION DE PROTÉINE KINASE ASSOCIÉE À RHO ET LE TRAITEMENT DE MALADIES
[EN] INDAZOLYL THIADIAZOLAMINES AND RELATED COMPOUNDS FOR INHIBITION OF RHO-ASSOCIATED PROTEIN KINASE AND THE TREATMENT OF DISEASE [FR] THIADIAZOLAMINES INDAZOLYLE ET COMPOSÉS APPARENTÉS POUR L'INHIBITION DE PROTÉINE KINASE ASSOCIÉE À RHO ET LE TRAITEMENT DE MALADIES
Palladium-catalyzed regiodivergent hydroaminocarbonylation of alkenes to primary amides with ammonium chloride
作者:Bao Gao、Guoying Zhang、Xibing Zhou、Hanmin Huang
DOI:10.1039/c7sc04054g
日期:——
the synthesis of primary amides has long been an elusive aim. Here, we report an efficient catalytic system which enables inexpensive NH4Cl to be utilized as a practical alternative to gaseous ammonia for the palladium-catalyzed alkene-hydroaminocarbonylation reaction. Through appropriate choice of the palladium precursors and ligands, either branched or linear primary amides can be obtained in good
[EN] METHOD FOR PREPARING SUBSTITUTED TRIAZOLOPYRIDINES<br/>[FR] PROCÉDÉ DE PRÉPARATION DE TRIAZOLOPYRIDINES SUBSTITUÉES
申请人:BAYER PHARMA AG
公开号:WO2014009219A1
公开(公告)日:2014-01-16
The present invention relates to methods of preparing substituted triazolopyridine compounds of general formula (I) as described and defined herein, as well as to intermediate compounds useful in the preparation of said compounds.
METHOD FOR PREPARING SUBSTITUTED TRIAZOLOPYRIDINES
申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20150148542A1
公开(公告)日:2015-05-28
The present invention relates to methods of preparing substituted triazolopyridine compounds of general formula (I) as described and defined herein, as well as to intermediate compounds useful in the preparation of said compounds.
[EN] SUBSTITUTED 1 H-PYRROLO[3,2-B]PYRIDIN COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS DE 1H-PYRROLO [3,2-B] PYRIDINE SUBSTITUÉS ET LEURS PROCÉDÉS D'UTILISATION
申请人:BAYER AG
公开号:WO2022023341A1
公开(公告)日:2022-02-03
Compounds of formula (I), processes for their production and their use as pharmaceuticals.